June 2020

Jun

Biofortuna appointed as CMO for QuantuMDx CE–marked assay

Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.

Biofortuna

Biofortuna is a trusted outsourcing partner for genomic services, custom development and contract manufacturing services.

Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.